Top

Published in:

01-06-2015 | Review

Long non-coding RNA functions in lung cancer

Authors: Haiwei Sang, Haihong Liu, Peng Xiong, Min Zhu

Published in: Tumor Biology | Issue 6/2015

Abstract

Numerous long non-coding RNAs (lncRNAs) have been discovered as a result of advances in sequencing methods in genomic research. Recent evidence indicates that lncRNAs may serve as gene regulators via various mechanisms, such as translational control. Dysregulation of lncRNAs contributes to the development and progression of several human diseases, notably lung cancer, which is one of the leading causes of cancer-associated death. Recent studies have identified key roles for molecules such as p53 and polycomb repressive complex 2 (PRC2) in carcinogenesis and the anti-carcinogenic action of lncRNAs. These findings point to the potential of lncRNAs as prospective diagnostic and prognostic biomarkers in lung cancer. In this review, we consider the functions of lncRNAs in translational control and discuss their involvement in lung cancer via p53, PRC2, and other pathways. We also consider the effects of modulating the levels and functions of lncRNAs. Further characterization of these lung cancer-associated lncRNAs will provide a better understanding of their potential roles as therapeutic targets.

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.

Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer J Int du Cancer. 2014. doi:10.1002/ijc.29210.

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O’Brien ME. Treatment options for small cell lung cancer—do we have more choice? Br J Cancer. 2010;102(4):629–38. doi:10.1038/sj.bjc.6605527.CrossRefPubMedPubMedCentral

Muralidaran A, Detterbeck FC, Boffa DJ, Wang Z, Kim AW. Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg. 2011;142(5):1137–42. doi:10.1016/j.jtcvs.2011.07.042.CrossRefPubMed

Othman N, Nagoor NH. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. BioMed Res Int. 2014;2014:318030. doi:10.1155/2014/318030.CrossRefPubMedPubMedCentral

Gao L, Mai A, Li X, Lai Y, Zheng J, Yang Q, et al. LncRNA-DQ786227-mediated cell malignant transformation induced by benzo(a)pyrene. Toxicol Lett. 2013;223(2):205–10. doi:10.1016/j.toxlet.2013.09.015.CrossRefPubMed

Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–307. doi:10.1016/j.cell.2013.02.012.CrossRefPubMedPubMedCentral

Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–8. doi:10.1038/nature11233.CrossRefPubMedPubMedCentral

Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications. Genet Res Int. 2012;2012:737416. doi:10.1155/2012/737416.PubMedPubMedCentral

10.

Yang Q, Zhang S, Liu H, Wu J, Xu E, Peng B, et al. Oncogenic role of long noncoding RNA AF118081 in anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells. Toxicol Lett. 2014;229(3):430–9. doi:10.1016/j.toxlet.2014.07.004.CrossRefPubMed

11.

Izzotti A, Pulliero A. The effects of environmental chemical carcinogens on the microRNA machinery. Int J Hyg Environ Health. 2014;217(6):601–27. doi:10.1016/j.ijheh.2014.01.001.CrossRefPubMed

12.

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–89. doi:10.1101/gr.132159.111.CrossRefPubMedPubMedCentral

13.

Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–9. doi:10.1038/nrg2521.CrossRefPubMed

14.

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358–69. doi:10.1016/j.cell.2011.09.028.CrossRefPubMedPubMedCentral

15.

Ng SY, Lin L, Soh BS, Stanton LW. Long noncoding RNAs in development and disease of the central nervous system. Trends Genet: TIG. 2013;29(8):461–8. doi:10.1016/j.tig.2013.03.002.CrossRefPubMed

16.

Zhang J, Zhang P, Wang L, Piao HL, Ma L. Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochim Biophys Sin. 2014;46(1):1–5. doi:10.1093/abbs/gmt117.CrossRefPubMed

17.

Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577–87. doi:10.1038/onc.2011.621.CrossRefPubMedPubMedCentral

18.

Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol: J Int Soc Oncodev Biol Med. 2013;34(2):613–20. doi:10.1007/s13277-013-0658-6.CrossRef

19.

Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420(6915):563–73. doi:10.1038/nature01266.CrossRefPubMed

20.

Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–41. doi:10.1038/sj.onc.1206928.CrossRefPubMed

21.

Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–66. doi:10.1016/j.canlet.2013.06.013.CrossRefPubMed

22.

Ponjavic J, Ponting CP, Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 2007;17(5):556–65. doi:10.1101/gr.6036807.CrossRefPubMedPubMedCentral

23.

Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180–9. doi:10.1158/0008-5472.CAN-12-2850.CrossRefPubMed

24.

Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma D, et al. Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin. Oncotarget. 2013;4(9):1427–37.CrossRefPubMedPubMedCentral

25.

Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):925–33. doi:10.4161/rna.24604.CrossRefPubMed

26.

Coulombe J, Gamage P, Gray MT, Zhang M, Tang MY, Woulfe J, et al. Loss of UCHL1 promotes age-related degenerative changes in the enteric nervous system. Front Aging Neurosci. 2014;6:129. doi:10.3389/fnagi.2014.00129.CrossRefPubMedPubMedCentral

27.

Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. 2012;491(7424):454–7. doi:10.1038/nature11508.CrossRefPubMed

28.

Lu X, Fang Y, Wang Z, Xie J, Zhan Q, Deng X, et al. Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. Cell Tissue Res. 2013;354(3):891–6. doi:10.1007/s00441-013-1711-x.CrossRefPubMed

29.

Mourtada-Maarabouni M, Williams GT. Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5. BioMed Res Int. 2013;2013:358015. doi:10.1155/2013/358015.CrossRefPubMedPubMedCentral

30.

Hu G, Lou Z, Gupta M. The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation. PLoS One. 2014;9(9), e107016. doi:10.1371/journal.pone.0107016.CrossRefPubMedPubMedCentral

31.

Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. 2013. doi:10.1002/mc.22120.

32.

Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M. Diminished WNT ->beta-catenin ->c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev. 2014;28(6):561–75. doi:10.1101/gad.233627.113.CrossRefPubMedPubMedCentral

33.

Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143(1):46–58. doi:10.1016/j.cell.2010.09.001.CrossRefPubMedPubMedCentral

34.

Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, et al. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J. 2013;32(20):2672–84. doi:10.1038/emboj.2013.188.CrossRefPubMedPubMedCentral

35.

Xu G, Chen J, Pan Q, Huang K, Pan J, Zhang W, et al. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014;9(8), e104044. doi:10.1371/journal.pone.0104044.CrossRefPubMedPubMedCentral

36.

Yang J, Lin J, Liu T, Chen T, Pan S, Huang W, et al. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer. 2014;85(2):110–5. doi:10.1016/j.lungcan.2014.05.011.CrossRefPubMed

37.

Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH, et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 2014;5, e1243. doi:10.1038/cddis.2014.201.CrossRefPubMedPubMedCentral

38.

Zhao W, An Y, Liang Y, Xie XW. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur Rev Med Pharmacol Sci. 2014;18(13):1930–6.PubMed

39.

Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;3(3):632–42. doi:10.1002/cam4.220.CrossRefPubMedPubMedCentral

40.

Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui X, Fewell C, et al. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol. 2013;6:35. doi:10.1186/1756-8722-6-35.CrossRefPubMedPubMedCentral

41.

Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregulation of p21(WAF1/CIP1) expression. PLoS One. 2013;8(10), e77293. doi:10.1371/journal.pone.0077293.CrossRefPubMedPubMedCentral

42.

Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun. 2013;436(2):319–24. doi:10.1016/j.bbrc.2013.05.101.CrossRefPubMed

43.

Liu XH, Liu ZL, Sun M, Liu J, Wang ZX, De W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer. 2013;13:464. doi:10.1186/1471-2407-13-464.CrossRefPubMedPubMedCentral

44.

Zhang L, Zhou XF, Pan GF, Zhao JP. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma. Biomed Pharmacother = Biomedecine Pharmacother. 2014;68(4):401–7. doi:10.1016/j.biopha.2014.03.001.CrossRef

45.

Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2014;35(6):5375–80. doi:10.1007/s13277-014-1700-z.CrossRef

46.

Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun M, et al. Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol: J Int Soc Oncodev Biol Med. 2014. doi:10.1007/s13277-014-2009-7.

47.

Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu C, et al. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. Int J Biochem Cell Biol. 2014;53:380–8. doi:10.1016/j.biocel.2014.06.004.CrossRefPubMed

48.

Whiteside EJ, Seim I, Pauli JP, O’Keeffe AJ, Thomas PB, Carter SL, et al. Identification of a long non-coding RNA gene, growth hormone secretagogue receptor opposite strand, which stimulates cell migration in non-small cell lung cancer cell lines. Int J Oncol. 2013;43(2):566–74. doi:10.3892/ijo.2013.1969.PubMed

49.

Thai P, Statt S, Chen CH, Liang E, Campbell C, Wu R. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol. 2013;49(2):204–11. doi:10.1165/rcmb.2013-0159RC.CrossRefPubMedPubMedCentral

50.

Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010;584(22):4575–80. doi:10.1016/j.febslet.2010.10.008.CrossRefPubMed

51.

Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thoracic Oncol: Off Publ Int Assoc Study Lung Cancer. 2011;6(12):1984–92. doi:10.1097/JTO.0b013e3182307eac.CrossRef

52.

Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3), e1003368. doi:10.1371/journal.pgen.1003368.CrossRefPubMedPubMedCentral

53.

Zhang J, Zhou Y, Wu Y, Ma L, Fan Y, Kang X, et al. Isolation and characterization of a novel noncoding RNA from nickel-induced lung cancer. Biol Trace Elem Res. 2012;150(1-3):258–63. doi:10.1007/s12011-012-9460-3.CrossRefPubMed

54.

Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45(8):1895–910. doi:10.1016/j.biocel.2013.05.030.CrossRefPubMed

55.

Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7(10):6929–35.PubMedPubMedCentral

56.

Luo J, Tang L, Zhang J, Ni J, Zhang HP, Zhang L, et al. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35(11):11541–9. doi:10.1007/s13277-014-2442-7.CrossRef

57.

Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14(1):268–77. doi:10.1158/1535-7163.mct-14-0492.CrossRefPubMed

58.

Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong R, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014;5, e1298. doi:10.1038/cddis.2014.256.CrossRefPubMedPubMedCentral

59.

Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014;13:68. doi:10.1186/1476-4598-13-68.CrossRefPubMedPubMedCentral

60.

Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One. 2013;8(5), e65309. doi:10.1371/journal.pone.0065309.CrossRefPubMedPubMedCentral

61.

Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013;49(6):1083–96. doi:10.1016/j.molcel.2013.01.010.CrossRefPubMed

62.

Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461. doi:10.1186/1471-2407-13-461.CrossRefPubMedPubMedCentral

63.

Han L, Kong R, Yin DD, Zhang EB, Xu TP, De W, et al. Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC. Med Oncol. 2013;30(4):694. doi:10.1007/s12032-013-0694-5.CrossRefPubMed

64.

Warin RF, Chen H, Soroka DN, Zhu Y, Sang S. Induction of lung cancer cell apoptosis through a p53 pathway by [6]-shogaol and its cysteine-conjugated metabolite M2. J Agric Food Chem. 2014;62(6):1352–62. doi:10.1021/jf405573e.CrossRefPubMedPubMedCentral

65.

Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet. 2010;19(R2):R152–61. doi:10.1093/hmg/ddq353.CrossRefPubMedPubMedCentral

66.

Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, Fellig Y, et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta. 2010;1803(4):443–51. doi:10.1016/j.bbamcr.2010.01.010.CrossRefPubMed

67.

Zhang A, Xu M, Mo YY. Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol. 2014;6(3):181–91. doi:10.1093/jmcb/mju013.CrossRefPubMedPubMedCentral

68.

Park JY, Lee JE, Park JB, Yoo H, Lee SH, Kim JH. Roles of long non-coding RNAs on tumorigenesis and glioma development. Brain Tumor Res Treatment. 2014;2(1):1–6. doi:10.14791/btrt.2014.2.1.1.CrossRef

69.

Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10(6):1193–8.PubMed

70.

Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012;279(17):3159–65. doi:10.1111/j.1742-4658.2012.08694.x.CrossRefPubMed

71.

Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002;23(11):1885–95.CrossRefPubMed

72.

Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30(47):4750–6. doi:10.1038/onc.2011.193.CrossRefPubMedPubMedCentral

73.

Sun M, Xia R, Jin F, Xu T, Liu Z, De W, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35(2):1065–73. doi:10.1007/s13277-013-1142-z.CrossRef

74.

Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350–8. doi:10.1158/0008-5472.can-09-3885.CrossRefPubMedPubMedCentral

75.

Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007;282(34):24731–42. doi:10.1074/jbc.M702029200.CrossRefPubMed

76.

Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell. 2004;15(1):57–67. doi:10.1016/j.molcel.2004.06.020.CrossRefPubMed

77.

Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667–72. doi:10.1073/pnas.0904715106.CrossRefPubMedPubMedCentral

78.

Huqun, Ishikawa R, Zhang J, Miyazawa H, Goto Y, Shimizu Y, et al. Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer. Cancer. 2012;118(6):1599–606. doi:10.1002/cncr.26441.CrossRefPubMed

79.

Li Z, Xu L, Tang N, Xu Y, Ye X, Shen S, et al. The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2. FEBS Lett. 2014. doi:10.1016/j.febslet.2014.05.057.

80.

Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–23. doi:10.1016/j.cell.2007.05.022.CrossRefPubMedPubMedCentral

81.

Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32(13):1616–25. doi:10.1038/onc.2012.193.CrossRefPubMed

82.

Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689–93. doi:10.1126/science.1192002.CrossRefPubMedPubMedCentral

83.

Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71(11):3852–62. doi:10.1158/0008-5472.can-10-4460.CrossRefPubMed

84.

Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–49. doi:10.1172/jci38019.CrossRefPubMedPubMedCentral

85.

Leinonen HM, Kansanen E, Polonen P, Heinaniemi M, Levonen AL. Role of the Keap1-Nrf2 pathway in cancer. Adv Cancer Res. 2014;122:281–320. doi:10.1016/b978-0-12-420117-0.00008-6.CrossRefPubMed

86.

Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes, Chromosomes Cancer. 2013;52(4):356–69. doi:10.1002/gcc.22032.CrossRefPubMed

87.

Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6:518. doi:10.1186/1756-0500-6-518.CrossRefPubMedPubMedCentral

88.

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6. doi:10.1038/nature08975.CrossRefPubMedPubMedCentral

89.

Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847–65. doi:10.1038/nrd4140.CrossRefPubMedPubMedCentral

90.

Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009;7:69. doi:10.1186/1479-5876-7-69.CrossRefPubMedPubMedCentral

Title: Long non-coding RNA functions in lung cancer
Authors: Haiwei Sang
Haihong Liu
Peng Xiong
Min Zhu
Publication date: 01-06-2015
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 6/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-3449-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2015

The roles of ADAMTS in angiogenesis and cancer

Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population

SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism

Association between GT-repeat polymorphism at heme oxygenase-1 gene promoter and gastric cancer and metastasis

Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progression

Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer